The global Automated Breast Ultrasound System (ABUS) Market reported a large market size in 2022, which is expected to expand significantly at a rapid CAGR during the forecast period. Industry analysis indicates that demand for Automated Breast Ultrasound System (ABUS) deployment and subsequent screening of patients is driven majorly by factors such as increasing prevalence of breast cancer as a result of hormone replacement therapy, obesity, rising preference to not bear child, and conditions and diseases caused by age. Increasing prevalence of breast cancer is resulting in increasing number of centers adopting ABUS, as this tool is a promising competitor to mammogram in screening of breast lesions.
An automated breast ultrasound system is specifically designed to create ultrasound images using a broadband transducer for scanning over the breast to capture 3D ultrasound volume data. ABUS provide 3D images and identify cancer in dense breast tissue. Advantages of ABUS include better diagnostic accuracy of breast lesions with regard to early detection, better categorization, and more accurate assessment. ABUS is operator-independent, and consumes less for screening and result, and entire breast scanning can be conducted with no ionizing radiation and no contraindication. Ultrasound in breast scan uses high frequency sound waves to create a black-and-white image of tissues and structures in the breast.
Request a Sample@ https://www.qyresearchmedical.com/sample/119464
This test is often recommended by doctors to assess the size and shape of lumps in the breast and ascertain if these are tumorous growths or fluid filled cysts. ABUS is quick, safe, and non-invasive, and women with dense breasts are at higher risk of developing breast cancer, and ABUS is effective in detecting mammographically occult cancer in women with dense tissue, while mammography has a lower sensitivity. Diagnostic radiologists can better see what cant be seen on the mammogram, and using an ultrasound and a mammogram together helps with detection at any age, and especially in the case of women with very dense breasts. In addition, symptomatic women 45 years or younger are recommended to get breast ultrasound as it is more accurate than mammography. On the other hand, mammography has progressive improvement in sensitivity in women 60 years and older.
The automated breast ultrasound systems (ABUS) market has been segmented by product and application, including hospitals and research laboratories and diagnostics imaging laboratories. Automated breast ultrasound systems enable faster scanning time and decreases operator dependence. It also improves the reproducibility, accuracy, reliability, and sensitivity of each individual’s complete breast ultrasound diagnosis.
Automated Breast Ultrasound System Market: Dynamics
Rapidly rising number of breast cancer cases worldwide is a major factor driving growth of the global automated breast ultrasound systems market. Other key factors resulting in rising prevalence of breast cancer are hormone replacement therapy, obesity, decreased childbearing, and age-related complications, which is turn is driving need for screening and need for more accurate diagnosis due to risks of further complications.
Continuous technological advancements in breast cancer detection systems is a primary driver for growth of the global Automated Breast Ultrasound System market. Industries are working on the development of a number of novel technologies to improve cancer screening in patients with dense breast cancer, thereby increasing the effectiveness of breast cancer detection. Also, advancements in ABUS are expected to overcome disadvantages in conventional systems. Such technological upgrades is also expected to result in increasing preference for more superior cancer imaging, thus driving growth of the automated breast ultrasound systems market.
However, high investment for automated breast ultrasound systems is a key factor expected to hamper growth of the market. Also, low awareness regarding automated breast ultrasound in emerging economies could hamper revenue growth to some extent over the forecast period. Furthermore, most insurance plans do not cover a breast screening ultrasound unlike screening mammograms, which is a factor restraining women in certain strata in society, especially in some developing economies, from getting ABUS screening.
Automated Breast Ultrasound System Market: Regional Landscape
The global Automated Breast Ultrasound System Market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for largest revenue share in 2020 due to increasing incidence of cancer and presence of major players in countries in the region. In addition, even women with no history of cancer are recommended under the U.S. screening guidelines to start receiving mammograms when they turn 40 or 50 years of age. They are also recommended to continue once every one or two years, and this is followed routinely till around 75 years of age. This is a key factor expected to support growth of the market in the region going ahead. Furthermore, breast cancer prevalence is relatively high in countries in North America. Around one in eight . (or around 13%) women in the U.S will develop invasive breast cancer over the course of lifetime. An estimated 281,550 new cases of invasive breast cancer are expected to be diagnosed in women in the U.S. in 2021, along with 49,290 new cases of non-invasive (in situ) breast cancer. As per Breastcancer.org, over 3.1 million women in the U.S. were suffering from breast cancer in January 2019. Going by these numbers and estimations, the market in the region is expected to register rapidly inclining revenue growth going ahead.
The Asia-Pacific market is expected to register the highest revenue growth during the forecast period as a result of increasing awareness and treatment of this type of cancer among women in countries in the region. Rising awareness, especially in some developing economies in the region, is resulting in more women approaching camps and centers for screening and diagnosis. Various organizations in countries in the region conduct breast cancer awareness programs, as well as programs to raise funds for research and development of more technologically innovative treatment processes.
Major Players Operating in the Automated Breast Ultrasound System Market:
- General Electric Company
- Hitachi, Ltd.
- Koninklijke Philips N.V.
- Siemens Healthineers AG
- Telemed Medical Systems
- Canon Medical Systems Corporation
- Fukuda Denshi
- Hologic, Inc.
- SonoCine Inc.
Automated Breast Ultrasound System (ABUS) Market: Segmentatio
This report provides historical data and forecasts for the Automated Breast Ultrasound System market at global, regional, and country levels. The report offers results of in-depth analysis and details regarding trends for regions, countries, segments, and consumer base from 2023 to 2032. For this study, has segmented the Automated Breast Ultrasound System Market based on product, application, and region.
By Product (Revenue, USD Billion; 2023–2032)
- Automated Breast Ultrasound System
- Automated Breast Volume Scanner
- Others
By Application (Revenue, USD Billion; 2023–2032)
- Hospitals
- Diagnostics Imaging Laboratories
- Clinics
- Others
Region Outlook (Revenue, USD Billion; 2023–2032)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Benelux
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East and Africa
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East & Africa
Buy quantitative research Report at discounted price – USD 1500 https://www.qyresearchmedical.com/report/checkout/119464/1500
You can place an order or ask any questions, please feel free to contact [email protected] | +1 9197 992 333
Blog: https://www.novaoneadvisor.com/
Blog: https://www.visionresearchreports.com/
About Us
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us:
URL – http://www.qyresearchmedical.com/
https://www.linkedin.com/company/qyresearch-medical/
https://www.facebook.com/QYResearch-Medical-108186514228917/